School of Medicine


Showing 321-325 of 325 Results

  • Nicolas Cuttriss

    Nicolas Cuttriss

    Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes

    Bio Dr. Cuttriss serves as Director of Project ECHO Diabetes at Stanford University. Prior to joining Stanford, Dr. Cuttriss served as the first pediatric endocrinologist for the University of New Mexico Project ECHO Institute ENDO teleECHO (www.echo.unm.edu) to democratize specialty knowledge and expand patients’ access to critical care and services in rural and underserved communities. Dr. Cuttriss co-founded and serves of chairman of the Board of AYUDA (www.ayudavolunteer.org), a global health volunteer organization that empowers youth to serve as agents of change for youth with diabetes. Dr. Cuttriss has supported diabetes outreach initiatives in over 10 countries, trained and placed over 700 students abroad. Dr. Cuttriss has special interest in telehealth, diabetes, and supporting vulnerable and underserved diabetes communities in the United States and globally.

  • Martha S. Cyert

    Martha S. Cyert

    Dr. Nancy Chang Professor

    Current Research and Scholarly Interests The Cyert lab is identifying signaling networks for calcineurin, the conserved Ca2+/calmodulin-dependent phosphatase, and target of immunosuppressants FK506 and cyclosporin A, in yeast and mammals. Cell biological investigations of target dephosphorylation reveal calcineurin’s many physiological functions. Roles for short linear peptide motifs, or SLiMs, in substrate recognition, network evolution, and regulation of calcineurin activity are being studied.

  • Agnieszka Czechowicz

    Agnieszka Czechowicz

    Assistant Professor of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly Interests Dr. Czechowicz’s research is aimed at understanding how hematopoietic stem cells interact with their microenvironment in order to subsequently modulate these interactions to improve bone marrow transplantation and unlock biological secrets that further enable regenerative medicine broadly. This work can be applied across a variety of disease states ranging from rare genetic diseases, autoimmune diseases, solid organ transplantation, microbiome-augmentation and cancer.

Latest information on COVID-19